Tag results:

Industry & Policy News

StemInov will Bioproduct the First Cell Therapy Drug To Treat Inflammatory Diseases

[StemInov [Businesswire]] StemInov will bioproduct the first cell therapy drug from umbilical cord stem cells for the treatment of inflammatory diseases, septic shock, and acute respiratory distress syndrome.

China’s Rolling COVID Waves Could Hit Every Six Months — Infecting Millions

[Nature] The latest surge is unlikely to crash the country’s health-care system, but scientists fear hundreds of millions of infections.

U of L Receives Grants for COVID-19 Research

[Kentucky Today] Researchers at the University of Louisville (U of L) have received federal grants totaling over $6 million for their work in understanding and preventing a serious complication that appears in some COVID-19 patients.

Non-Invasive Approach for Electrical Nerve Stimulation Among Six Projects Supported by 2023 Connaught Innovation Awards

[University of Toronto Engineering News] Professor Paul Yoo had been designing novel electrodes for non-invasive electrical nerve stimulation, a technology that could be used in therapies for the treatment of epilepsy, depression, Parkinson’s disease, and many pain disorders.

UTHealth Houston Receives Federal Funding for Traumatic Brain Injury Research

[UTHealth Houston] Nearly $13 million in federal grant funds to study treatments for traumatic brain injury was awarded to UTHealth Houston by the Department of Defense’s Office of Congressionally Directed Medical Research Programs.

FDA Oncology Head Wants Advisory Panels to Keep Voting on New Drugs

[STAT News] As commissioner of FDA, Robert Califf has made clear he would like to do away with the votes that punctuate meetings of expert panels evaluating new drugs for approval.

Popular